Taro Hitosugi

5PUBLICATIONS
41CO-AUTHORS
Speciation and extinctionMolecular targetsMetabolic medicineCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 29, 2026
Mitochondrial metabolism and epigenetic crosstalk drive SASP.

|Oct 08, 2025
Non-canonical dihydrolipoyl transacetylase promotes chemotherapy resistance via mitochondrial tetrahydrofolate signaling.

Jung Seok Hwang, JiHoon Kang, Jaehyun Kim

|Sep 11, 2024
CPT2-mediated Fatty Acid Oxidation Is Dispensable for Humoral Immunity.

Meilu Li, Xian Zhou, Yanfeng Li

|Nov 15, 2023
Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8+ T cells via ME1 up-regulation.

Joanina K Gicobi, Zhiming Mao, Grace DeFranco

|Jul 06, 2021
Enzymatic activation of pyruvate kinase increases cytosolic oxaloacetate to inhibit the Warburg effect.

Elizabeth K Wiese, Sadae Hitosugi, Sharon T Loa

Pageof 1

Frequent Collaborators

2 joint publications

Hu Zeng

1 joint publications

Yuan-Ping Pang

1 joint publications

Joanina K Gicobi

1 joint publications

Zhiming Mao